Dopamine D4 receptors and the risk of cigarette smoking in African- Americans and Caucasians

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 6, 1998, Pages 453-458

  Shields, Peter G ^a   Lerman, Caryn ^b   Audrain, Janet ^b   Bowman, Elise D ^a   Main, David ^b   Boyd, Neil R ^c   Caporaso, Neil E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 4 RECEPTOR;

ALLELE; ARTICLE; CAUCASIAN; DOPAMINERGIC TRANSMISSION; GENE LOCATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HABITUATION; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; RACE DIFFERENCE; REWARD; SMOKING; SMOKING CESSATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMERASE CHAIN REACTION; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SMOKING; SMOKING CESSATION;

EID: 0031879906     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Dani, J. A., and Heinemann, S. Molecular and cellular aspects of nicotine abuse. Neuron, 16: 905-908, 1996.
2. Paulson, G W. Addiction to nicotine is due to high intrinsic levels of dopamine. Med. Hypotheses, 38: 206-207, 1992.
3. Balfour, D. J. Neural mechanisms underlying nicotine dependence. Addiction, 89: 1419-1423, 1994.
4. Nisell, M , Nomikos, G. G., and Svensson, T. H. Nicotine dependence, midbrain dopamine systems, and psychiatric disorders. Pharmacol Toxicol., 76: 157-162, 1995.
5. Leshner, A. I Molecular mechanisms of cocaine addiction. N. Engl J. Med , 335: 128-129, 1996.
6. Wise, R. A., and Rompre, P. P. Brain dopamine and reward. Annu. Rev. Psychol., 40: 191-225, 1989.
7. Caporaso, N E , Lerman, C , Main, D , Audrain, J , Boyd, N R , Bowman, E., Lockshin, B., and Shields, P. The genetics of smoking: the dopamine receptor (DRD2) and transporter (DAT) polymorphisms in a smoking cessation study. Proc Am Assoc Cancer Res., 38: 168-169, 1997.
8. Comings, D E , Ferry, L., Bradshaw-Robinson, S , Burchette, R , Chiu, C., and Muhleman, D. The dopamine D2 receptor (DRD2) gene, a genetic risk factor in smoking Pharmacogenetics, 6: 73-79, 1996.
9. Noble, E P., St. Jeor, S. T., Ritchie, T , Syndulko, K., St. Jeor, S. C , Fitch, R. J., Brunner, R L., and Sparkes, R S, D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses, 42: 257-260, 1994.
10. O'Dowd, B. F. Structures of dopamine receptors J Neurochem , 60: 804-816, 1993.
11. Civelli, O , Bunzow, J. R , Grandy, D. K., Zhou, Q Y., and Van Tol, H. H. Molecular biology of the dopamine receptors. Eur J Pharmacol., 207; 277-286, 1991.
12. Seeman, P. Dopamine receptors. In: F E. Bloom and D. J. Kupfer (eds.), Psychopharmacology: Fourth Generation of Progress, pp. 295-302. New York: Raven Press, Ltd , 1995.
13. Bloom, F. E., and Roth, R. H. Dopamine. In: J. R. Cooper, F. E. Bloom, and R. H. Roth (eds), The Biochemical Basis of Neuropharmacology, pp. 293-351. New York: Oxford University Press, 1996.
14. Van Tol, H. H., Bunzow, J. R., Guan, H. C., Sunahara, R. K., Seeman, P., Niznik, H. B , and Civelli, O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature (Lond.), 350: 610-614, 1991.
15. Lahti, R. A., Evans, D L , Stratman, N. C., and Figur, L. M. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications Eur J Pharmacol., 236: 483-486, 1993.
16. Seeman, P., Guan, H. C., and Van Tol, H. H. Dopamine D4 receptors elevated in schizophrenia. Nature (Lond.), 365: 441-445, 1993.
17. Reynolds, G. P., and Mason, S. L. Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia. Eur. J Pharmacol, 281: R5-R6, 1995.
18. Van Tol, H. H., Wu, C. M., Guan, H. C., Ohara, K , Bunzow, J. R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H. B., and Jovanovic, V. Multiple dopamine D4 receptor variants in the human population Nature (Lond.), 358: 149-152, 1992.
19. Matsumoto, M , Hidaka, K., Tada, S., Tasaki, Y , and Yamaguchi, T. Full-length cDNA cloning and distribution of human dopamine D4 receptor. Mol. Brain Res., 29: 157-162, 1995.
20. Asghari, V., Sanyal, S., Buchwaldt, S., Paterson, A., Jovanovic, V., and Van Tol, H. H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem, 65: 1157-1165, 1995.
21. Rao, P. A., Pickar, D., Gejman, P. V., Ram, A., Gershon, E. S., and Gelernter, J Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch. Gen. Psychiatry, 51: 912-917, 1994.
22. Lerman, C., Gold, K., Audrain, J., Lin, T. H., Boyd, N. R., Orleans, C. T , Wilfond, B., Louben, G , and Caporaso, N. Incorporating biomarkers of exposure and genetic susceptiblity into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol, 16: 87-99, 1997.
23. George, S. R., Cheng, R., Nguyen, T., Israel, Y , and O'Dowd, B F. Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem. Biophys. Res Commun., 196: 107-114, 1993.
24. Benjamin, J., Li, L., Patterson, C., Greenberg, B. D., Murphy, D. L., and Hamer, D. H. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat. Genet., 12: 81-84, 1996.
25. Asghari, V , Schoots, O., van Kats, S., Ohara, K , Jovanovic, V., Guan, H. C., Bunzow, J. R., Petronis, A., and Van Tol, H. H. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol. Pharmacol., 46: 364-373, 1994.
26. Seeman, P., Ulpian, C., Choumard, G., Van Tol, H. H., Dwosh, H., Lieberman, J. A., Siminovitch, K., Liu, I. S., Waye, J., Voruganti, P , Hudson, C., Serjeant, G R , Masibay, A. S , and Seeman, M. V. Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophrenia. Am J. Med. Genet., 54: 384-390, 1994.
27. Nothen, M. M., Cichon, S., Hemmer, S., Hebebrand, J., Remschmidt, H., Lehmkuhl, G., Poustka, F., Schmidt, M , Catalano, M., Fimmers, R , Korner, R., Rietschel, M., and Propping, P. Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Hum. Mol. Genet., 3: 2207-2212, 1994.
28. Liu, I. S., Seeman, P., Sanyal, S., Ulpian, C., Rodgers-Johnson, P. E., Serjeant, G R., and Van Tol, H. H. Dopamine D4 receptor variant in Africans, D4valine194glycine, is insensitive to dopamine and clozapine: report of a homozygous individual. Am. J. Med. Genet., 61: 277-282, 1996.
29. Ebstein, R. P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blame, D., Bennett, E. R., Nemanov, L , Katz, M., and Belmaker, R. H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet., 12: 78-80, 1996.
30. Malhotra, A. K., Virkkunen, M., Rooney, W , Eggert, M., Linnoila, M., and Goldman, D. The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiatry, 1: 388-391, 1996.
31. LaHoste, G. J , Swanson, J. M., Wigal, S. B., Glabe, C., Wigal, T., King, N., and Kennedy, J. L. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry, 1: 121-124, 1996.
32. Grice, D. E., Leckman, J. F., Pauls, D. L., Kurlan, R., Kidd, K. K , Pakstis, A. J., Chang, F. M , Buxbaum, J. D., Cohen, D. J , and Gelernter, J. Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test Am. J. Hum. Genet, 59: 644-652, 1996.
33. Lim, L. C., Nothen, M. M., Korner, J., Rietschel, M., Castle, D., Hunt, N., Propping, P., Murray, R., and Gill, M. No evidence of association between dopamine D4 receptor variants and bipolar affective disorder. Am J. Med. Genet , 54: 259-263, 1994.
34. Petronis, A., Macciardi, F., Athanassiades, A , Paterson, A. D., Verga, M., Meltzer, H. Y., Cola, P., Buchanan, J. A , Van Tol, H. H., and Kennedy, J. L. Association study between the dopamine D4 receptor gene and schizophrenia. Am. J Med. Genet., 60: 452-455, 1995.
35. Daniels, J., Williams, J., Mant, R., Asherson, P., McGuffin, P., and Owen, M. J. Repeat length variation in the dopamine D4 receptor gene shows no evidence of association with schizophrenia. Am. J. Med. Genet, 54: 256-258, 1994.
36. Center for Disease Control. Cigarette smoking among adults - United States, 1994. Morb Mortal. Wkly. Rep., 45: 588-590, 1996.
37. Center for Disease Control. Smoking: attributable mortality and years of potential life lost - United States, 1988. Morb. Mortal. Wkly Rep. 40: 64-71, 1991.
38. Ries, L. A , Hankey, B. F., and Edwards, B. K. Cancer Statistics Review: 1973-1994. National Cancer Institute Publ. No. 97, p. 2789. Bethesda, MD: NIH, 1997.
39. Escobedo, L. G., Anda, R. F., Smith, P. P., Remington, P L., and Mast, E E. Sociodemographic characteristics of cigarette smoking initiation in the United States: implications for smoking prevention policy. J. Am. Med. Assoc., 264: 1550-1555, 1990.
40. Headen, S. W., Bauman, K. E , Deane, G. D., and Koch, G. G. Are the correlates of cigarette smoking initiation different for black and white adolescents? Am. J. Public Health, 81: 854-858, 1991.
41. Cummings, K. M., Giovino, G , and Mendicino, A. J. Cigarette advertising and black-white differences in brand preference. Public Health Rep., 102: 698-701, 1987.
42. Rabat, G. C., Morabia, A., and Wynder, E. L. Comparison of smoking habits of blacks and whites in a case-control study. Am. J. Public Health, 81: 1483-1486, 1991.
43. Orleans, C. T., Schoenbach, V J., Salmon, M. A., Strecher, V J., Kalsbeek, W., Quade, D., Brooks, E. F., Konrad, T. R., Blackmon, C., and Watts, C D. A survey of smoking and quitting patterns among black Americans. Am. J. Public Health, 79: 176-181, 1989.
44. Royce, J. M., Hymowitz, N., Corbett, K., Hartwell, T. D , and Orlandi, M. A. Smoking cessation factors among African Americans and whites. COMMIT Research Group. Am J. Public Health, 83: 220-226, 1993.
45. Hoffman, A., Cooper, R , Lacey, L., and Mullner, R. Cigarette smoking and attitudes toward quitting among black patients. J. Am. Med. Assoc , 81: 415-420, 1989.
46. Novotny, T. E., Warner, K. E., Kendnck, J. S., and Remington, P. L. Smoking by blacks and whites: socioeconomic and demographic differences Am. J. Public Health, 78: 1187-1189, 1988.
47. Center for Disease Control. The Health Benefits of Smoking Cessation (Department of Health and Human Services Publication No. 90-8416). Rockville, MD: United States Department of Health and Human Services, 1990.
48. Gritz, E. R., Berman, B A., Bastani, R., and Wu, M. A randomized trial of a self-help smoking cessation intervention in a nonvolunteer female population: testing the limits of the public health model. Health Psychol, 11: 280-289, 1992.
49. Orleans, C T., Schoenbach, V. J , Wagner, E. H., Quade, D., Salmon, M. A , Pearson, D. C., Fiedler, J., Porter, C. Q., and Kaplan, B. H Self-help quit smoking interventions: effects of self-help materials, social support instructions, and telephone counseling. J. Consult. Clin. Psychol., 59: 439-448, 1991.
50. Russell, M. A., Stapleton, J. A., Feyerabend, C., Wiseman, S M., Gustavsson, G., Sawe, U., and Connor, P. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. Br Med J , 306: 1308-1312, 1993.
51. Ahluwalia, J. S. Smoking cessation in African Americans. Am. J. Health Behavior, 20: 312-318, 1996.
52. Lichter, J B., Barr, C. L., Kennedy, J. L., Van Tol, H H., Kidd, K. K., and Livak, K J. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum. Mol. Genet, 2: 767-773, 1993.
53. Chang, F. M., Kidd, J. R., Livak, K. J., Pakstis, A. I., and Kidd, K. K The worldwide distribution of allele frequencies at the human dopamine D4 receptor locus Hum. Genet., 98: 91-101, 1996.